|
1
|
Xu Y, Yu X, Chen Q and Mao W: Neoadjuvant
versus adjuvant treatment: Which one is better for resectable
esophageal squamous cell carcinoma? World J Surg Oncol. 10:1732012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in esophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rice TW, Rusch VW, Apperson-Hansen C,
Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE,
et al: Worldwide esophageal cancer collaboration. Dis Esophagus.
22:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shapiro IM, Cheng AW, Flytzanis NC,
Balsamo M, Condeelis JS, Oktay MH, Burge CB and Gertler FB: An
EMT-driven alternative splicing program occurs in human Breast
Cancer and Modulates Cellular Phenotype. PLoS Genet.
7:e10022182011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumor progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niwa Y, Yamada S, Koike M, Kanda M, Fujii
T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M and Kodera Y:
Epithelial to mesenchymal transition correlates with tumor budding
and predicts prognosis in esophagealsquamous cell carcinoma. J Surg
Oncol. 110:764–769. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin H, Morohashi S, Sato F, Kudo Y,
Akasaka H, Tsutsumi S, Ogasawara H, Miyamoto K, Wajima N, Kawasaki
H, et al: Vimentin expression of esophageal squamous cell carcinoma
and its aggressive potential for lymph node metastasis. Biomed Res.
31:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang F, Li XK, Xu HY, Shan ZZ, Wang T,
Yang ZC, He W, Wang LX and Fan QX: N-cadherin participated in
invasion and metastasis of human esophageal squamous cell carcinoma
via taking part in the formation of vasculogenic mimicry. Med
Oncol. 32:4802015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong H, Xie L, Tang C, Chen S, Liu Q,
Zhang Q, Zheng W, Zheng Z and Zhang H: Snail1 correlates with
patient outcomes in E-cadherin-preserved gastroesophageal junction
adenocarcinoma. Clin Transl Oncol. 16:783–791. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Forghanifard MM, Moaven O, Farshchian M,
Montazer M, Raeisossadati R, Abdollahi A, Moghbeli M, Nejadsattari
T, Parivar K and Abbaszadegan MR: Expression analysis elucidates
the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma
aggressiveness and metastasis. Ann Surg Oncol. 19:743–749. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gong T, Xue Z, Tang S, Zheng X, Xu G, Gao
L, Zhao G, Hong L, Tang G, Zhang H, et al: Nuclear expression of
Twist promotes lymphatic metastasis in esophageal squamous cell
carcinoma. Cancer Biol Ther. 13:606–613. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee KW, Kim JH, Han S, Sung CO, Do IG, Ko
YH, Um SH and Kim SH: Twist1 is an independent prognostic factor of
esophageal squamous cell carcinoma and associated with its
epithelial-mesenchymal transition. Ann Surg Oncol. 19:326–335.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song X, Han P, Liu J, Wang Y, Li D, He J,
Gong J, Li M, Tu W, Yan W, et al: Up-regulation of SPOCK1 induces
epithelial-mesenchymal transition and promotes migration and
invasion inesophageal squamous cell carcinoma. J Mol Histol.
46:347–356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang N, Liu F, Cao F, Jia Y, Wang J, Ma W,
Tan B, Wang K, Song Q and Cheng Y: RACK1 predicts poor prognosis
and regulates progression of esophageal squamous cell carcinoma
through its epithelial-mesenchymal transition. Cancer Biol Ther.
16:528–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beck TN, Chikwem AJ, Solanki NR and
Golemis EA: Bioinformatic approaches to augment study of
epithelial-to-mesenchymal transition in lung cancer. Physiol
Genomics. 46:699–724. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Postigo AA, Depp JL, Taylor JJ and Kroll
KL: Regulation of Smad signaling through a differential recruitment
of coactivators and corepressors by ZEB proteins. EMBO J.
22:2453–2462. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hegarty SV, Sullivan AM and O'Keeffe GW:
Zeb2: A multifunctional regulator of nervous system development.
Prog Neurobiol. 132:81–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
National Comprehensive Cancer Network.
(NCCN) Clinical Practice Guidelines in Oncology. Esophageal and
Esophagogastric Junction Cancers. version 1. 2015.https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#esophageal
|
|
23
|
Hao XP, Pretlow TG, Rao JS and Pretlow TP:
Beta-catenin expression is altered in human colonic aberrant crypt
foci. Cancer Res. 61:8085–8088. 2001.PubMed/NCBI
|
|
24
|
Jolly MK, Boareto M, Huang B, Jia D, Lu M,
Ben-Jacob E, Onuchic JN and Levine H: Implications of the Hybrid
Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol.
5:1552015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du HF, Ou LP, Yang X, Song XD, Fan YR, Tan
B, Luo CL and Wu XH: A new PKCα/β/TBX3/E-cadherin pathway is
involved in PLCε-regulated invasion and migration in human bladder
cancer cells. Cell Signal. 26:580–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu W, Tian Y, Wan H, Ma J, Song Y, Wang Y
and Zhang L: Expression of β-catenin and E- and N-cadherin in human
brainstem gliomas and clinicopathological correlations. Int J
Neurosci. 123:318–323. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koay MH, Crook M and Stewart CJ: Cyclin
D1, E-cadherin and beta-catenin expression in FIGO Stage IA
cervical squamous carcinoma: Diagnostic value and evidence for
epithelial-mesenchymal transition. Histopathology. 61:1125–1133.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carneiro P, Figueiredo J, Bordeira-Carriço
R, Fernandes MS, Carvalho J, Oliveira C and Seruca R: Therapeutic
targets associated to E-cadherin dysfunction in gastric cancer.
Expert Opin Ther Targets. 17:1187–1201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu TA, Jan YJ, Ko BS, Liang SM, Chen SC,
Wang J, Hsu C, Wu YM and Liou JY: 14-3-3ε overexpression
contributes to epithelial-mesenchymal transition of hepatocellular
carcinoma. PLoS One. 8:e579682013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoshida R, Morita M, Shoji F, Nakashima Y,
Miura N, Yoshinaga K, Koga T, Tokunaga E, Saeki H, Oki E, et al:
Clinical Significance of SIP1 and E-cadherin in Patients with
Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 22:2608–2614.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Muir AB, Dods K, Noah Y, Toltzis S,
Chandramouleeswaran PM, Lee A, Benitez A, Bedenbaugh A, Falk GW,
Wells RG, et al: Esophageal epithelial cells acquire functional
characteristics of activated myofibroblasts after undergoing an
epithelial to mesenchymal transition. Exp Cell Res. 330:102–110.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang WK, Liao LD, Zeng FM, Zhang PX, Wu
JY, Shen J, Xu LY and Li EM: Desmocollin-2 affects the adhesive
strength and cytoskeletal arrangement in esophageal squamous cell
carcinoma cells. Mol Med Rep. 10:2358–2364. 2014.PubMed/NCBI
|
|
33
|
Wong TS, Gao W and Chan JY: Transcription
regulation of E-cadherin by zinc finger E-box binding homeobox
proteins in solid tumors. Biomed Res Int. 2014:9215642014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bhardwaj M, Sen S, Sharma A, Kashyap S,
Chosdol K, Pushker N, Bajaj MS and Bakhshi S: ZEB2/SIP1 as novel
prognostic indicator in eyelid sebaceous gland carcinoma. Hum
Pathol. 46:1437–1442. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Prislei S, Martinelli E, Zannoni GF,
Petrillo M, Filippetti F, Mariani M, Mozzetti S, Raspaglio G,
Scambia G and Ferlini C: Role and prognostic significance of the
epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.
Oncotarget. 6:18966–18979. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Galván JA, Zlobec I, Wartenberg M, Lugli
A, Gloor B, Perren A and Karamitopoulou E: Expression of E-cadherin
repressors SNAIL, ZEB1 and ZEB2 by tumor and stromal cells
influences tumor-budding phenotype and suggests heterogeneity of
stromal cells in pancreatic cancer. Br J Cancer. 112:1944–1950.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miyoshi A, Kitajima Y, Sumi K, Sato K,
Hagiwara A, Koga Y and Miyazaki K: Snail and SIP1 increase cancer
invasion by upregulating MMP family in hepatocellular carcinoma
cells. Br J Cancer. 90:1265–1273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Davalos V, Moutinho C, Villanueva A, Boque
R, Silva P, Carneiro F and Esteller M: Dynamic epigenetic
regulation of the microRNA-200 family mediates epithelial and
mesenchymal transitions in human tumorigenesis. Oncogene.
31:2062–2074. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun X, Sun Z, Zhu Z, Li C, Zhang J, Xu H
and Sun M: Expression of SIP1 is strongly correlated with LDHA and
shows a significantly poor outcome in gastric cancer. Tumour Biol.
36:7521–7530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jouppila-Mättö A, Mannermaa A, Sironen R,
Kosma VM, Soini Y and Pukkila M: SIP1 predicts progression and poor
prognosis in pharyngeal squamous cell carcinoma. Histol
Histopathol. 30:569–579. 2015.PubMed/NCBI
|
|
41
|
Kong YH, Syed Zanaruddin SN, Lau SH,
Ramanathan A, Kallarakkal TG, Vincent-Chong VK, Wan Mustafa WM,
Abraham MT, Abdul Rahman ZA, Zain RB and Cheong SC: Co-Expression
of TWIST1 and ZEB2 in oral squamous cell carcinoma is associated
with poor Survival. PLoS One. 10:e01340452015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Miura N, Yano T, Shoji F, Kawano D,
Takenaka T, Ito K, Morodomi Y, Yoshino I and Maehara Y:
Clinicopathological significance of Sip1-associated epithelial
mesenchymal transition in non-small cell lung cancer progression.
Anticancer Res. 29:4099–4106. 2009.PubMed/NCBI
|
|
43
|
Mehendiratta M, Solomon MC, Boaz K,
Guddattu V and Mohindra A: Clinico-pathological correlation of
Ecadherin expression at the invasive tumor front of Indian oral
squamous cell carcinomas: An immunohistochemical study. J Oral
Maxillofac Pathol. 18:217–222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mostaan LV, Khorsandi MT, Sharifian SM,
Shandiz FH, Mirashrafi F, Sabzari H, Badiee R, Borghei H and
Yazdani N: Correlation between E-cadherin and CD44 adhesion
molecules expression and cervical lymph node metastasis in oral
tongue SCC: Predictive significance or not. Pathol Res Pract.
207:448–451. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gamba CO, Campos LC, Negreiros-Lima GL,
Maciel-Lima K, Sousa LP, Estrela-Lima A, Ferreira E and Cassali GD:
ZEB2 and ZEB1 expression in a spontaneous canine model of invasive
micropapillary carcinoma of the mammary gland. Res Vet Sci.
97:554–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fang Y, Wei J, Cao J, Zhao H, Liao B, Qiu
S, Wang D, Luo J and Chen W: Protein expression of ZEB2 in renal
cell carcinoma and its prognostic significance in patient survival.
PLoS One. 8:e625582013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu
BC, Chen YW, Huang PI and Lo WL: Epithelial-mesenchymal transition
transcription factor ZEB1/ZEB2 co-expression predicts poor
prognosis and maintains tumor-initiating properties in head and
neck cancer. Oral Oncol. 49:34–41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Okugawa Y, Inoue Y, Tanaka K, Kawamura M,
Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y and Kusunoki M: Smad
interacting protein 1 (SIP1) is associated with peritoneal
carcinomatosis in intestinal type gastric cancer. Clin Exp
Metastasis. 30:417–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sayan AE, Griffiths TR, Pal R, Browne GJ,
Ruddick A, Yagci T, Edwards R, Mayer NJ, Qazi H, Goyal S, et al:
SIP1 protein protects cells from DNA damage-induced apoptosis and
has independent prognostic value in bladder cancer. Proc Natl Acad
Sci USA. 106:14884–14889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Maeda G, Chiba T, Okazaki M, Satoh T, Taya
Y, Aoba T, Kato K, Kawashiri S and Imai K: Expression of SIP1 in
oral squamous cell carcinomas: Implications for E-cadherin
expression and tumor progression. Int J Oncol. 27:1535–1541.
2005.PubMed/NCBI
|
|
51
|
Torlakovic EE, Nielsen S, Vyberg M and
Taylor CR: Getting controls under control: The time is now for
immunohistochemistry. J Clin Pathol. 68:879–882. 2015. View Article : Google Scholar : PubMed/NCBI
|
